stars 1 stars 2 stars 3

For additional information on our community guidelines, please visit https://www.novartis.com/corporate-social-media-community-management-guidelines

Website http://www.morphosys.com
Ticker MOR
Revenue $258.6 million
Funding $2 billion
Employees 143 (103 on RocketReach)
Founded 1992
Phone +49 89 899270
Fax +49 89 89927222
Technologies
Industry Biotechnology Research, Drug Manufacturing & Research, Biotechnology, Therapeutic Antibodies, Pharmaceuticals, Science and Engineering, Cancer, Healthcare, Health Diagnostics, Inflammation, Health Care, Biologics, Medical, Antibodies, Monoclonal Antibodies, Clinical Development, Phage Display
Web Rank 2 Million
Keywords Therapeutic Antibodies, Cancer Treatment, Biopharmaceutical, Immunology Research, Drug Development, Biotechnology, Pharmaceutical Research, Clinical Trials, Oncology, Immuno-Oncology, Protein Engineering, Drug Discovery, Biologics, Molecular Biology, Pharmaceutical, Medicine Development, Healthcare, Life Sciences, Research And Development
Competitors Roche, Ablynx, Genmab, Novartis, Amgen, Regeneron, Bristol Myers Squibb, AbbVie, Pfizer, AstraZeneca +43 more (view full list)
SIC SIC Code 873 Companies, SIC Code 87 Companies
NAICS NAICS Code 541 Companies, NAICS Code 541712 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541711 Companies

MorphoSys Questions

The MorphoSys annual revenue was $258.6 million in 2026.

Arkadius Pichota is the CEO of MorphoSys.

103 people are employed at MorphoSys.

The NAICS codes for MorphoSys are [541, 541712, 5417, 54171, 54, 541711].

The SIC codes for MorphoSys are [873, 87].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users